Oncology
2290 articles · 70 journals
Journals in this subcategory (70)
- EJC Skin Cancer · Elsevier (91)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (90)
- Blood Neoplasia · Elsevier (90)
- The Lancet Oncology · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (85)
- European Journal of Surgical Oncology · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (81)
- International Journal of Gynecological Cancer · Elsevier (80)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (69)
- European Journal of Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (67)
- Leukemia Research Reports · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (64)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (54)
- The Journal of Liquid Biopsy · Elsevier (53)
- Leukemia Research · Elsevier (52)
- Cancer Letters · Elsevier (51)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Current Problems in Cancer: Case Reports · Elsevier (30)
- Journal of Geriatric Oncology · Elsevier (30)
- Journal of Bone Oncology · Elsevier (29)
- Intelligent Oncology · Elsevier (20)
- Precision Radiation Oncology · Wiley (20)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- Best Practice & Research Clinical Haematology · Elsevier (12)
- npj Precision Oncology · Springer Nature (12)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- British Journal of Cancer · Springer Nature (8)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- P0119: Evaluation of Volume-Based Rectal Dose and Late Adverse Events After Definitive Radiotherapy for Cervical Cancer a Prospective Study
- P0120: Simulation-Free Vaginal Cuff Brachytherapy for High-Intermediate Risk Endometrial Cancer
- P0201: Comparison of Mean Rectal Spacing Between Hyaluronic Acid and Polyethylene Glycol
- Oncofetal chondroitin sulfate on tumor-derived extracellular vesicles: an emerging multivalent target for liquid biopsy
- Rewiring the tumor microenvironment: IGFBP2 at the Nexus of remodeling and therapy resistance?
- ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma
- Olutasidenib as maintenance therapy after treatment response in acute myeloid leukemia with persistent IDH1 mutation
- Deletion 11q, monosomy 13, and deletion 13q in noncomplex karyotype acute myeloid leukemia
- Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia
- Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden
- The ER stress-autophagy axis in cancer-induced muscle wasting: Unveiling the IRE1α/XBP1 pathway as a therapeutic target
- Recent advances on AI-driven decoding of tertiary lymphoid structures in precision cancer immunotherapy
- The molecular landscape of chordoma: Current frontiers from multi-omics to artificial intelligence
- Liquid biopsy for molecular profiling in cutaneous T-cell lymphoma: a pilot feasibility study
- Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial
- Epigenetics as a mechanism of lineage extinction and relapse of B-cell lymphoma treated with CD19 CAR T-cell therapy
- Ten-day decitabine vs “3+7” in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21
- Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics
- Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations
- Dynamic protein trafficking shapes ferroptosis sensitivity and immunogenicity
- Nano meets CAR-T: A new era in cancer immunotherapy
- Macrophages as central mediators of perineural invasion in cancer: Implications for pain and prognosis
- Research advances in the recurrence patterns of glioblastoma
- Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort
- Predicting long-term metastatic risk after radical prostatectomy: Adding Genomic Prostate Score, grade group, and cribriform size to unfavorable histology burden translates into minimal incremental discrimination
- Quantitative core-level tumor burden and grading in MRI-targeted vs. systematic prostate biopsy: A within-patient paired analysis
- Intraductal carcinoma of the prostate does not independently predict adverse outcomes after radical prostatectomy: A National Cancer Database analysis
- Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer
- Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trial
- Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial